Equities analysts expect Markel Co. (NYSE:MKL) to post earnings of $8.71 per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Markel’s earnings, with estimates ranging from $7.79 to $10.27. Markel posted earnings of $2.82 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 208.9%. The firm is scheduled to announce its next earnings report on Wednesday, April 25th.
According to Zacks, analysts expect that Markel will report full-year earnings of $36.49 per share for the current fiscal year, with EPS estimates ranging from $33.61 to $40.00. For the next year, analysts anticipate that the business will report earnings of $38.21 per share, with EPS estimates ranging from $36.63 to $41.00. Zacks’ EPS calculations are a mean average based on a survey of research firms that that provide coverage for Markel.
Markel (NYSE:MKL) last posted its quarterly earnings results on Tuesday, February 6th. The insurance provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.55 by ($1.91). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.58 billion. Markel had a net margin of 6.52% and a return on equity of 0.39%.
MKL stock traded down $0.32 during trading on Friday, hitting $1,153.51. 32,993 shares of the company’s stock traded hands, compared to its average volume of 29,342. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.60 and a quick ratio of 0.60. Markel has a 52 week low of $936.95 and a 52 week high of $1,194.98. The firm has a market cap of $16,039.27, a price-to-earnings ratio of 318.65 and a beta of 0.89.
In other Markel news, CEO Richard R. Whitt III sold 300 shares of the business’s stock in a transaction on Friday, February 9th. The shares were sold at an average price of $1,060.02, for a total transaction of $318,006.00. Following the completion of the sale, the chief executive officer now owns 9,652 shares in the company, valued at $10,231,313.04. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Alan I. Kirshner sold 100 shares of the company’s stock in a transaction dated Monday, April 2nd. The stock was sold at an average price of $1,149.02, for a total transaction of $114,902.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,800 shares of company stock valued at $2,012,582. 2.53% of the stock is owned by insiders.
Institutional investors have recently added to or reduced their stakes in the company. Aevitas Wealth Management Inc. bought a new position in shares of Markel during the fourth quarter worth about $108,000. First Personal Financial Services grew its position in shares of Markel by 156.1% during the fourth quarter. First Personal Financial Services now owns 105 shares of the insurance provider’s stock worth $120,000 after acquiring an additional 64 shares during the last quarter. SeaCrest Wealth Management LLC bought a new position in shares of Markel during the fourth quarter worth about $122,000. Simplex Trading LLC grew its position in shares of Markel by 169.1% during the fourth quarter. Simplex Trading LLC now owns 148 shares of the insurance provider’s stock worth $168,000 after acquiring an additional 93 shares during the last quarter. Finally, Cigna Investments Inc. New bought a new position in shares of Markel during the fourth quarter worth about $201,000. Institutional investors and hedge funds own 78.15% of the company’s stock.
Markel Company Profile
Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, the United Kingdom, Canada, and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment offers general and professional liability, property, personal line, program, and workers' compensation insurance products, as well as other insurance product lines, such as ocean marine, surety, CPI, and coverages.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.